Long-Term Subgroup Analyses from L-Mind, a Phase II Study of Tafasitamab (MOR208) Combined with Lenalidomide in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
| Autor: | Maddocks, Kami J., Duell, Johannes *, González-Barca, Eva *, Jurczak, Wojciech *, Liberati, Anna Marina, de Vos, Sven, Nagy, Zsolt *, Obr, Aleš *, Gaidano, Gianluca, Abrisqueta, Pau *, André, Marc *, Dreyling, Martin, Menne, Tobias F *, Dirnberger-Hertweck, Maren *, Weirather, Johannes *, Ambarkhane, Sumeet, Salles, Gilles |
|---|---|
| Zdroj: | In Blood 5 November 2020 136 Supplement 1:19-21 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|